Enhancement of anti-leukemia activity of NK cells<i>in vitro</i>and<i>in vivo</i>by inhibition of leukemia cell-induced NK cell damage
Roberto Arriga(University of Rome Tor Vergata), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Soldano Ferrone(Massachusetts General Hospital), Luca Maurillo(University of Rome Tor Vergata), Sara Caratelli(National Academies of Sciences, Engineering, and Medicine), Giulio C. Spagnoli(National Academies of Sciences, Engineering, and Medicine), Davide Lauro(University of Rome Tor Vergata), Giulia Lanzilli(Istituto di Farmacologia Traslazionale), Maria Ilaria Del Principe(University of Rome Tor Vergata), Patrizia Palomba(University of Rome Tor Vergata), Tommaso Sconocchia(Istituto di Farmacologia Traslazionale), Barbara Capuani(University of Rome Tor Vergata), Sergio Amadori(Polyclinic Medical Center), Andrea Coppola(University of Rome Tor Vergata), Adriano Venditti(University of Rome Tor Vergata), Francesco Buccisano(University of Rome Tor Vergata)
Cited by 13
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k